Malignant Atrophic Papulosis – Degos Disease
Degos disease, also called malignant atrophic papulosis (MAP), is an extremely rare, serious and persistent occlusive disorder of the small blood vessels. It is marked by progressive blockage of small arterioles and capillaries in the skin, gastrointestinal tract and central nervous system. Its skin lesions are a true signature in dermatology: raised red papules quickly evolve into round lesions with a sharply defined, sunken, porcelain-white center surrounded by a halo of dilated vessels (a telangiectatic rim). There are two main forms: benign cutaneous Degos disease, which is limited to the skin, and malignant systemic Degos disease, which involves internal organs. In the systemic form, vessel blockage in the intestinal lining causes ischemia and necrosis, leading to bowel perforation and peritonitis, the leading cause of death in these patients. At Haute-Derma, our approach covers recognition of the typical porcelain-white lesions, wedge biopsy for histopathology, regular screening tests for internal organ involvement, and advanced treatment with antiplatelet agents and complement inhibitors.
How the disease develops in the skin and immune system:
- Endothelial Dysfunction and Thrombotic Microangiopathy:
- Primary injury to the endothelial cells of superficial and deep dermal arterioles causes them to swell and die, and they lose their natural anticoagulant properties.
- Platelets clump at the site and fibrin is deposited, forming clots that fill the vessel and completely cut off blood flow to the overlying skin.
- Complement-Mediated Autoimmunity and Interferon Alpha (IFN-alpha):
- Increased deposition of the complement membrane attack complex (C5b-9) is found in small vessel walls and the basement membrane.
- Overactivation of type I interferon (IFN-alpha) signaling drives chronic inflammation of small vessels and damages the microcirculatory barrier.
- Wedge-Shaped Necrosis and Central Epidermal Atrophy:
- Because the blocked arteriole lies in the deep dermis, the area of ischemia is wedge-shaped, with its apex at the occluded vessel and its base toward the epidermis.
- Complete loss of blood supply at the center of the lesion leads to necrosis, hyalinization of dermal collagen and shrinking of the epidermis (producing the porcelain-white color), while the surrounding border grows new small vessels to compensate (producing the red telangiectatic halo).
Clinical Stages of Degos Disease
| Clinical Presentation | How to Recognize the Lesions | Cellular and Molecular Mechanism |
|---|---|---|
| Early Stage (Initial Red Papules) | Slightly raised pink-red papules, 2–5 mm, painless and not itchy, appearing on the trunk and limbs. | Early blockage of superficial dermal arterioles, causing mild inflammation and congestion around the vessels. |
| Typical Stage (Porcelain-White Papules) | Papules with a sunken, porcelain- or eggshell-white center, sharp borders and a pink-red or telangiectatic rim. | Hyaline necrosis of dermal collagen from wedge-shaped ischemia; compensatory vessel dilation at the border. |
| Late Stage (Depressed Atrophic Scars) | Small ivory-white atrophic scars with a fixed, sunken groove; the red rim fades, but the lesions are permanent. | Complete epidermal atrophy and dermal fibrosis after the vascular necrosis. |
| Gastrointestinal Involvement (Malignant Form) | Episodes of acute abdominal pain, nausea, gastrointestinal bleeding, and bowel perforation with peritonitis. | Small-vessel blockage in the bowel lining and muscle causes ischemic necrosis of the bowel wall. |
| Neurological Involvement (Malignant Form) | Headache, ischemic stroke, cranial nerve damage, seizures. | Occlusive inflammation of small vessels in the meninges and brain tissue. |
Degos Disease vs. Lichen Sclerosus and Leukocytoclastic Vasculitis
| Degos Disease | Lichen Sclerosus | Leukocytoclastic Vasculitis (LCV) |
|---|---|---|
| Thrombotic small-vessel occlusion with necrosis | Loss of elasticity, sclerotic epidermal atrophy | Inflammatory necrosis of the vessel wall |
| Papules with a porcelain-white center and a red telangiectatic rim | Pearly white plaques without a red rim | Raised hemorrhagic papules (palpable purpura) |
| Trunk, arms and legs (sparing the face and palms) | Genitals, perineum, back | Lower legs, pressure areas |
| Bowel perforation, stroke (often fatal) | No internal organ involvement | Kidney inflammation, joint pain, mild abdominal pain |
| Wedge-shaped necrosis, thrombotic occlusion | Superficial dermal edema, band-like sclerosis | Fibrinoid necrosis, leukocytoclasis (nuclear dust) |
Our Approach
At Haute-Derma, diagnosing Degos disease calls for great care, both to catch lesions early and to tell the benign skin-limited form apart from the malignant systemic form:
- Full-Thickness Skin Biopsy:
- The biopsy takes the whole thickness of a porcelain-white papule with a red rim, including the deep dermis and subcutis.
- Characteristic findings: wedge-shaped collagen necrosis, epidermal atrophy, loss of skin appendages, clots occluding dermal arterioles, and a sparse inflammatory infiltrate.
- Dermoscopy: We look for a structureless, avascular, porcelain-white center surrounded by radially arranged telangiectasias (crown vessels) at the edge.
- Systemic Screening and Close Follow-Up: For every patient with Degos skin lesions: regular upper endoscopy and colonoscopy, brain MRI, fecal occult blood testing, CRP and ESR, and complement levels (C3, C4, C5b-9).
Treatment Options at Haute-Derma
Degos disease is one of the most difficult conditions to treat in dermatology. Our treatment plan focuses on blocking platelet aggregation, targeting complement, and protecting the skin:
- Current Systemic Medications:
- Dual antiplatelet therapy: low-dose aspirin combined with clopidogrel (75 mg/day) helps prevent new clots forming in small vessels.
- Complement inhibitors and vasodilators (eculizumab/treprostinil): the anti-C5 antibody eculizumab or the prostacyclin analog treprostinil has shown benefit in published case reports, improving small-vessel damage and limiting bowel perforation in the malignant form.
- Intravenous immunoglobulin (IVIG) or immunosuppressants: considered as add-on treatment during severe flares of small-vessel inflammation.
- Skin Barrier Repair and Protection at Haute-Derma:
- Preventing secondary infection: ceramide-based repair moisturizers, plus topical erythromycin/bupivacaine on papules that have been scratched open.
- Red (630 nm) and near-infrared (830 nm) LED therapy: helps improve microcirculation in the surrounding skin and encourages repair of the shrunken, fibrotic tissue around the porcelain-white lesions.
- Patient Monitoring and Warning Signs:
- Close follow-up every 3 months: we teach patients to recognize warning signs of bowel perforation (severe abdominal pain, fever, vomiting) or neurological symptoms so they can seek emergency care without delay.
